KELLY BADURA: Open Payments
NPI 1730226804 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,621 in 77 payments from 14 companies in 2025. Trend: 2023 $1,617 · 2024 $1,975 · 2025 $1,621
Food & beverage: $1,621
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 25 | $658 |
| Novo Nordisk Inc | 19 | $383 |
| Lilly USA, LLC | 10 | $178 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $64 |
| PFIZER INC. | 4 | $60 |
| Abbott Laboratories | 3 | $58 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| ABBVIE INC. | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $22 |
Products named: AIRSUPRA, BREZTRI, Wegovy, MOUNJARO, Ozempic, Kerendia, NURTEC ODT, FARXIGA.
Industry payments across TN — which companies pay providers there.
